Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Orphanix

Orphanix?uq=UG6efJS6
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of drugs for rare diseases. The company formulates drugs for diseases which are not very common among humans.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
  • Peter Roseggerstrasse 41
  • Ried im Innkreis, 4910
  • Austria

+43 0676 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Orphanix’s full profile, request a free trial.

Orphanix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 15-Jun-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Orphanix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
tech2b Accelerator/Incubator 000 0000 000000 0

Orphanix Executive Team (1)

Name Title Board
Seat
Contact
Info
Philipp Novak Founder & Chief Executive Officer